Umbilical Cord Blood Stem Cell Market is Expected to Reach $56.4 Billion, Globally, by 2020
Cord blood stem cell application is increasing a faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting the healthcare industry to discover novel therapies for chronic diseases. UCB stem cell market is evidenced significant growth due to increasing public awareness and government support. "state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.
Roshan Deshmukh
Allied Market Research today announced the most comprehensive and strategically analyzed report titled World Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020" The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012. Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4% during 2013 to 2020.The storage service market was valued at $7.4billion in 2013.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries, however patents for UCB stem cells are comparatively less in developing economies.
According to lead analyst Debbie Shields, the geographic analysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies. Company profiles in this report include - Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.
Talk to David (Europe)
Talk to Sona Padman (Americas)
5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91 2066346060
Fax: +1(855) 550-5975
Shaun Godinho
Communications Officer
Allied Market
Research
Contact Toll Free: +1-800-792-5285
Drop us an email
at
media@alliedmarketresearch.com
Stem Cell Umbilical Cord Blood (UCB) Market by Diseases (Cancer/ Oncology diseases, Chronic Leukemia, Myelodysplastic Syndrome, Blood diseases, Beta Thalassemia, Sickle Cell disease, Wiskott-Aldrich, Hurler Syndrome, Sanfilippo Syndrome, Osteopetrosis), Technology (Stem Cell Transplant, Autologous, Allogenic, Regenerative Medicine, Cord Blood Banking, Blood Transfusion, Cell Based Genetics ) - Global Opportunity Analysis and Industry Forecast, 2012 - 2020
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
Targeted Market View
Targeted market view to provide pertinent information and save time of readers
Featured Readings
Get Fresh content delivered
Get insights on topics that matter to your business. Stay updated on the area that interests you.
Buy Full Version
"Umbilical Cord Blood Stem Cell Market"
Purchase Enquiry